Patents and other intellectual property rights are critical elements in the market Ipsogen evolves in. The Company frequently files patents to protect its technological processes and products. Ipsogen frequently acquires licenses and patent rights from external parties, academic partners or players in the diagnostic industry.

Ipsogen’s patent portfolio covers two main types of patents: technologies and processes to manufacture diagnostic tests and biomarker including genomic signatures (multivariate indexes) or unique molecular markers.
Ipsogen’s patent portofolio is owned in proper name, co-owned or exploited as licenses acquired from French or International academic institutions and private companies.

  
• Site Map  
• Contact us  
• Legal notice